From: Mediation analysis of the relationship between institutional research activity and patient survival
Trial hospitals | Non-trial hospitals | |||
---|---|---|---|---|
No. of patients, N (%) | 219 | (62.2) | 133 | (37.8) |
Age (years) | ||||
Median (IQR) | 64 | (57–73) | 66 | (56–74) |
Performance status, N (%) | ||||
ECOG 0/1 | 166 | (75.8) | 101 | (75.9) |
ECOG > 1 | 53 | (24.2) | 32 | (24.1) |
Ascites, N (%) | ||||
≤ 500 ml | 113 | (51.6) | 59 | (44.4) |
> 500 ml | 106 | (48.4) | 74 | (55.6) |
Comorbidity, N (%) | ||||
None | 166 | (75.8) | 91 | (68.4) |
Present | 53 | (24.2) | 42 | (31.6) |
Histology, N (%) | ||||
Serous | 167 | (76.3) | 96 | (72.2) |
Other | 52 | (23.7) | 37 | (27.8) |
Grade, N (%) | ||||
G 1/2 | 97 | (44.3) | 69 | (51.9) |
G 3/4 | 122 | (55.7) | 64 | (48.1) |